Orthopaedic Research UK has launched this year’s Ronald Furlong Fund for startups solving unmet needs in MSK health.
Named in honour of the charity’s founder, who combined a successful career as an orthopaedic surgeon with an equally successful career as an entrepreneur, the Fund offers up to £100K to UK-based startups to help accelerate innovative and commercially viable ideas.
Previous recipients of the Ronald Furling Fund include Radii Devices, which deploys s AI and biomechanical modelling to help clinicians design better fitting prosthetic sockets; Novara Therapeutics, which is commercialising the world’s first patented bio-specific solution for the targeted diagnosis and treatment of bone microfractures , and Renovos Biologics, which is pioneering the use of a nanoclay in injectable gel form that can carry biologic drugs capable of augmenting bone tissue regeneration.
The deadline for applications is Monday 9 June 2025 at 11:59pm.
Find further information on the Ronald Furlong Fund page.